CN Patent
CN103040824B — 信号通路抑制剂及其制备方法和用途
Assigned to Sichuan University · Expires 2015-05-27 · 11y expired
What this patent protects
本发明属于化学医药技术领域,特别涉及信号通路抑制剂及其制备方法和用途。信号通路抑制剂,结构如式Ⅰ所示,通过实验证明了以上所示信号通路抑制剂对Hedgehog信号通路的IC 50 在30nM~10μM,可用于制备治疗与Hedgehog信号通路异常激活有关的疾病。
USPTO Abstract
本发明属于化学医药技术领域,特别涉及信号通路抑制剂及其制备方法和用途。信号通路抑制剂,结构如式Ⅰ所示,通过实验证明了以上所示信号通路抑制剂对Hedgehog信号通路的IC 50 在30nM~10μM,可用于制备治疗与Hedgehog信号通路异常激活有关的疾病。
Drugs covered by this patent
- Erivedge (vismodegib) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.